| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 1 | 100 |
Sells | $0 | 0 | 0 |
| Angulo Gonzalez David | Chief Executive Officer | 1 | $0 | 0 | $0 | $0 |
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
Over the last 12 months, insiders at SCYNEXIS, Inc. have bought $0 and sold $0 worth of SCYNEXIS, Inc. stock.
On average, over the past 5 years, insiders at SCYNEXIS, Inc. have bought $87,633 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 108,695 shares for transaction amount of $0 was made by Angulo Gonzalez David (Chief Executive Officer) on 2026‑04‑01.
| 2026-04-01 | Angulo Gonzalez David | Chief Executive Officer | 108,695 – | $0 | $0 | -31.93% | ||
| 2024-09-12 | Angulo Gonzalez David | Chief Executive Officer | 20,000 0.054% | $1.37 | $27,400 | -25.00% | ||
| 2022-04-26 | Taglietti Marco | Chief Executive Officer | 75,000 0.226% | $3.00 | $225,000 | -8.26% | ||
| 2022-04-26 | Sukenick Scott | General Counsel | 3,500 0.0105% | $3.00 | $10,500 | -8.26% | ||
| 2021-01-22 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 319,000 1.2567% | $8.24 | $2.63M | -12.08% | |
| 2021-01-21 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 95,000 0.3717% | $7.38 | $701,100 | -2.46% | |
| 2021-01-20 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 185,000 0.717% | $7.43 | $1.37M | -3.77% | |
| 2020-12-21 | Taglietti Marco | Chief Executive Officer | 40,000 0.3797% | $6.25 | $250,000 | +17.98% | ||
| 2020-12-21 | Angulo Gonzalez David | Chief Medical Officer | 1,600 0.0152% | $6.25 | $10,000 | +17.98% | ||
| 2020-12-21 | Macdonald Guy | director | 8,000 0.0759% | $6.25 | $50,000 | +17.98% | ||
| 2020-12-21 | Francois Eric | Chief Financial Officer | 600 0.0057% | $6.25 | $3,750 | +17.98% | ||
| 2020-12-21 | Sukenick Scott | General Counsel | 1,600 0.0152% | $6.25 | $10,000 | +17.98% | ||
| 2020-12-21 | Tinmouth Brian Philippe | director | 8,000 0.0759% | $6.25 | $50,000 | +17.98% | ||
| 2020-12-21 | ANIDO ARMANDO | director | 5,000 0.0475% | $6.25 | $31,250 | +17.98% | ||
| 2020-12-21 | GILMAN STEVEN C | director | 4,000 0.038% | $6.25 | $25,000 | +17.98% | ||
| 2020-12-21 | HANHAM ANN | director | 3,200 0.0304% | $6.25 | $20,000 | +17.98% | ||
| 2019-12-12 | Taglietti Marco | Chief Executive Officer | 333,334 0.461% | $1.00 | $333,334 | -0.94% | ||
| 2019-08-21 | Taglietti Marco | Chief Executive Officer | 19,000 0.0171% | $0.56 | $10,545 | -19.28% | ||
| 2019-08-20 | Taglietti Marco | Chief Executive Officer | 1,000 0.0009% | $0.56 | $555 | -19.19% | ||
| 2019-08-15 | Taglietti Marco | Chief Executive Officer | 20,030 0.0349% | $1.01 | $20,230 | -12.98% |
| Angulo Gonzalez David | Chief Executive Officer | 1357126 21.5803% | $5.35M | 13 | 0 | +14.44% |
| ALTA BIOPHARMA PARTNERS II LP | 10 percent owner | 1240575 19.727% | $4.89M | 1 | 0 | |
| Ventech Capital II | 10 percent owner | 414211 6.5866% | $1.63M | 1 | 0 | |
| Nothias Jean-Yves | director | 295077 4.6922% | $1.16M | 1 | 0 | |
| FCPR Biotechnology Fund | 10 percent owner | 295077 4.6922% | $1.16M | 1 | 0 | |
| Taglietti Marco | Chief Executive Officer | 272068 4.3263% | $1.07M | 30 | 0 | +4.55% |
| F.C.P.R. Genavent | 10 percent owner | 237598 3.7782% | $936,136.12 | 1 | 0 | |
| Machado Patrick | director | 60000 0.9541% | $236,400.00 | 2 | 0 | +14.14% |
| Sukenick Scott | General Counsel | 53499 0.8507% | $210,786.06 | 3 | 0 | +0.36% |
| HASTINGS DAVID C | director | 31834 0.5062% | $125,425.96 | 2 | 0 | <0.0001% |
| Macdonald Guy | director | 12000 0.1908% | $47,280.00 | 2 | 0 | +25.36% |
| Francois Eric | Chief Financial Officer | 11732 0.1866% | $46,224.08 | 3 | 0 | +14.03% |
| Tinmouth Brian Philippe | director | 8000 0.1272% | $31,520.00 | 1 | 0 | +17.98% |
| ANIDO ARMANDO | director | 5000 0.0795% | $19,700.00 | 1 | 0 | +17.98% |
| GILMAN STEVEN C | director | 4000 0.0636% | $15,760.00 | 1 | 0 | +17.98% |
| HANHAM ANN | director | 3622 0.0576% | $14,270.68 | 2 | 0 | +5.51% |
| Increased Positions | 16 | +30.19% | 2M | +21.07% |
| Decreased Positions | 19 | -35.85% | 5M | -45.5% |
| New Positions | 6 | New | 2M | New |
| Sold Out Positions | 10 | Sold Out | 4M | Sold Out |
| Total Postitions | 50 | -5.66% | 9M | -24.43% |
| Avidity Partners Management Lp | $2,138.00 | 7.98% | 3.35M | +2M | +172.64% | 2025-09-30 |
| Kingdon Capital Management, L.L.C. | $1,427.00 | 5.33% | 2.24M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $1,124.00 | 4.2% | 1.76M | +105,600 | +6.37% | 2025-09-30 |
| Federated Hermes, Inc. | $1,010.00 | 3.77% | 1.58M | -1M | -45.31% | 2025-09-30 |
| Geode Capital Management, Llc | $268.00 | 1% | 419,448 | +983 | +0.23% | 2025-09-30 |
| Acadian Asset Management Llc | $266.00 | 0.99% | 416,602 | -7,900 | -1.86% | 2025-09-30 |
| Blackrock, Inc. | $214.00 | 0.8% | 334,648 | 0 | 0% | 2025-09-30 |
| Amh Equity Ltd | $157.00 | 0.59% | 245,939 | -15,142 | -5.8% | 2025-09-30 |
| Yakira Capital Management, Inc. | $121.00 | 0.45% | 189,802 | 0 | 0% | 2025-09-30 |
| Renaissance Technologies Llc | $111.00 | 0.42% | 174,600 | +14,800 | +9.26% | 2025-09-30 |